Better understanding of the earliest stages of human development and the opportunity to improve fertility treatment and prevent miscarriages are goals of the British researcher who just received permission from United Kingdom (U.K.) regulators to use a powerful new genome editing technique on human embryos in the lab.
Dr. Kathy Niakan of London’s Francis Crick Institute will be using the new gene editing technique, known as Crispr or Crispr-Cas9, which allows researchers to perform a sort of cut and paste with DNA.
